Cancer risk in HIV, transplant patients

HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to a land mark paper in The Lancet.

The research, which is led by Professor Andrew Grulich from the University of New South Wales’ National Centre in HIV Epidemiology and Clinical Research (NCHECR), suggests that immune deficiency – which is common to the two groups – is responsible for the increased risk.

The paper is the first in the world to compare cancer rates between the populations.

HIV/AIDS patients are 11 times more likely to develop Hodgkin’s lymphoma – a cancer associated with Epstein Barr Virus - while there is almost four times the risk for those who have a transplant.

There are a number of cancers associated with human papilloma virus, from cervical cancer to cancers of the mouth, penis and anus. In both these populations, all of these cancers were significantly increased.

“The only thing that people with AIDS and transplant recipients share is immune deficiency, otherwise their risk factors for cancer differ markedly,” said the lead author, Professor Grulich, of the paper, which has been selected for editorial comment in the journal.

“In other cancers, which are not linked with viruses, such as breast and prostate cancer, both groups had similar rates to the general population,” he said.

“Until now, the accepted wisdom was that there were only three cancers associated with HIV – this paper finds that it is more like 20.”

One of those three cancers which was already known to be linked with HIV is Kaposi’s sarcoma. In that population, there is a 3,640-fold increased likelihood for patients to develop the disease. This research shows that there is also a marked increase in transplant patients – they are 208 times more likely to develop the cancer than the general population.

Professor Grulich suggests the results could have implications for the way HIV/AIDS patients are treated.

“This evidence suggests that immune deficiency is associated with risk of cancer and this suggests we need to maintain people’s immune systems at a higher level – and that might mean putting HIV patients on anti-retroviral drugs earlier than is currently the case,” he said.

The researchers now plan to look at cancer rates of those with congenital immune deficiency and people who have received other transplanted organs.

Source: University of New South Wales

Related stories:

Blood vessel inhibitor shows promise against metastatic thyroid cancer
Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of The New England Journal of Medicine.
Circulating tumor cells can reveal genetic signature of dangerous lung cancers
Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy. A pilot study of the device called the CTC-chip will appear in the July 24 New England Journal of Medicine and is receiving early online release.
Analysis of cancer incidence, mortality and survival combined reveals encouraging European trends
The first research to look at recent trends in European cancer incidence, mortality and survival together has shown that cancer prevention and management in Europe is moving in the right direction. However, the research reveals that variations between countries in policies for mass screening, access to health care and treatment are reflected in the different cancer rates.
3-D mammograms, cameras may improve breast exams
(AP) -- Remember peeking through a View-Master? Scientists are using the same concept behind the classic kids' toy to try to see mammograms in 3-D. The goal: A better way to check for breast cancer in women with breasts too dense for today's mammograms to give a clear picture.
Cancer 'cure' in mice to be tested in humans
Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice.
Faulty DNA repair could be a risk factor for lung cancer in nonsmokers
People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability, according to researchers from the Department of Epidemiology at The University of Texas M. D. Anderson Cancer Center.
Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show
(Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease.
Certain anticancer agents could be harmful to patients with heart disease
A set of promising new anticancer agents could have unforeseen risks in individuals with heart disease, suggests research at Washington University School of Medicine in St. Louis. The anticancer drugs — which go by the strange name of hedgehog antagonists — interfere with a biochemical process that promotes growth in some cancer cells. But the researchers showed that interfering with this biochemical process in mice with heart disease led to further deterioration of cardiac function and ultimately death.

News discussion:

Medicine & Health news